Latest News
Via The Motley Fool · July 11, 2025
A steady dose of quality companies will keep your portfolio growing big and strong.
Via The Motley Fool · July 11, 2025
The Oracle of Omaha's $616 million "secret" portfolio holds stakes in two quantum computing pioneers.
Via The Motley Fool · July 11, 2025
Via The Motley Fool · July 11, 2025
Via The Motley Fool · July 11, 2025
Most Wall Street analysts see substantial upside in these technology stocks.
Via The Motley Fool · July 11, 2025
Via The Motley Fool · July 11, 2025
Via The Motley Fool · July 11, 2025
NICE LTD (NASDAQ:NICE) is a high-quality stock with strong profitability, low debt, and solid growth prospects, making it a compelling candidate for long-term investors.
Via Chartmill · July 11, 2025
In this video, Ira Epstein discusses the current state of the metals market as of July 10, 2025, highlighting gold's struggle to maintain the $3,300 level and silver's strong performance above $37 an ounce.
Via Talk Markets · July 11, 2025
Renewed momentum in the crypto sector surged BTC Digital Ltd (NASDAQ: BTCT) stocks by 29.33% in after-hours trading on Thursday.
Via Benzinga · July 11, 2025
IBM and Oracle look undervalued relative to their growth potential.
Via The Motley Fool · July 11, 2025
The stock is up over 200% in the past year. It could be a sign of what's to come for long-term investors.
Via The Motley Fool · July 11, 2025
The company has provided income and stability in an industry that has historically been volatile.
Via The Motley Fool · July 11, 2025
Perella Weinberg Partners (PWP) shows strong earnings momentum and a bullish technical setup, making it a stock to watch for growth investors. High EPS and revenue growth, combined with a solid chart structure, suggest potential upside.
Via Chartmill · July 11, 2025
Currently, as the President of Beauty & Wellbeing at Unilever, London, Nair is responsible for a €13 billion portfolio that ranges across hair care, skin care, prestige beauty, health, and wellbeing.
Via Stocktwits · July 11, 2025
The FDA’s Orphan Drug Designation offers incentives like seven years of U.S. market exclusivity, tax credits for clinical trials, and a waiver of the user fee for its ALS gene therapy.
Via Stocktwits · July 11, 2025
Third Point's billionaire chief showed Tesla the door and loaded up on the hottest name in the artificial intelligence (AI) arena during the first quarter.
Via The Motley Fool · July 11, 2025
Many investors have soured on this former market darling, but that may be a "go" sign for new buyers in light of its quiet and underappreciated progress on the AI front.
Via The Motley Fool · July 11, 2025
There is evidence that trading on Robinhood is more expensive than trading on competing platforms, AG claims.
Via Stocktwits · July 11, 2025
Tesla to expand Robotaxi service to Phoenix, Arizona amid plans to expand to San Francisco Bay Area pending regulatory approvals.
Via Benzinga · July 11, 2025